FTC Questions Apple News Over Alleged Bias Against Conservative Media 
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions 
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal 
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth 
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed 
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains 
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks 
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims 
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase 
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports 
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week 
SOUTH SAN FRANCISCO, Calif., Feb. 14, 2018 -- Fluidigm Corporation (NASDAQ:FLDM) today announced that the company’s management will participate in two upcoming investor conferences.
Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will participate in the fifth annual BTIG Healthcare Conference, focused on medical technology, life sciences, and diagnostic tools, in Snowbird, Utah, on Wednesday, February 28, and Thursday, March 1.
Linthwaite and Jog will also participate in the Cowen and Company 38th Annual Health Care Conference at the Boston Marriott Copley Place in Boston, Massachusetts. Linthwaite will present on Tuesday, March 13, 2018, at 9:20 am ET, with a breakout to follow at 10:00 am ET.
A live webcast of the company’s presentation and subsequent replay may be accessed at http://investors.fluidigm.com/events.cfm. The webcast will be archived for 90 days following the live presentation.
About Fluidigm
Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets life science analytical and preparatory systems for markets such as mass cytometry, high-throughput genomics, and single-cell genomics. We sell to leading academic institutions, clinical research laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide. Our systems are based on proprietary microfluidics and multiparameter mass cytometry technology and are designed to significantly simplify experimental workflow, increase throughput, and reduce costs while providing excellent data quality. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.
Fluidigm and the Fluidigm logo are trademarks and/or registered trademarks of Fluidigm Corporation.
Contact:
Fluidigm Corporation
Ana Petrovic
Director, Corporate Development and Investor Relations
650 243 6628 (office)
[email protected]
